FdaApplication
ANDA 220367
Identifiers
- fda_app_no: ANDA220367
Properties
| Property | Value |
|---|---|
| applicant_name | STERANCO HEALTHCARE PVT LTD |
| application_type | ANDA |
| approval_date | 2026-02-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NYSTATIN | NYSTATIN | 100,000 UNITS/ML | SUSPENSION;ORAL |
1 product